Solasta Ventures is a venture capital firm that specializes in investing in early-stage technology startups. The firm focuses on companies that are developing breakthrough scientific solutions and disruptive technologies in various sectors such as artificial intelligence, life sciences, and sustainable energy.

Solasta Ventures

EvolveImmune Therapeutics is a company developing precision cancer medicines to deliver patient outcomes compared to current anti-cancer therapies.

EvolveImmune Therapeutics

Solasta Ventures, Inc. (formerly known in the U.S. as Aju IB Investment) is a wholly-owned subsidiary of Aju IB Investment, a leading South Korean venture capital firm.

We are committed to investing in innovative companies that advance the standard of care for diseases with unmet medical needs. Our team leverages deep scientific expertise and an extensive network to identify promising therapeutics and discovery platforms that have the potential to transform patients’ lives worldwide.

Tibit Communications

Seer

Rallybio

Rapt Therapeutics

Kezar Life Sciences

Kymera Therapeutics

Carisma Therapeutics

Xilio Therapeutics, Inc.

Apellis Pharmaceuticals

Arcellx

Atea Pharmaceuticals

Metric
Company Name	Solasta Ventures	EvolveImmune Therapeutics
Symbol
MSH ID	COM:SOLASTA-VENTURES	COM:EVOLVEIMMUNE
Market	PRIVATE	PRIVATE
Sector	Financial Services & Finance	Healthcare & Health Services
Industry	Venture Capital & Private Equity	Biotechnology
Country	US	US
Stage
Employee Count	5
Website	solasta-ventures.com	evolveimmune.com
LinkedIn	solasta-ventures
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	326
Web Traffic Growth	-0.60
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:SOLASTA-VENTURES

Solasta Ventures

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue